CGT Catapult Advanced Therapies Seminar with the University of Oxford

Actions and Detail Panel

Sales Ended

Sales Have Ended

Registrations are closed
If you wish to receive a recording of this event, please contact comms@ct.catapult.org.uk

Event Information

Share this event

Date and time

Location

Location

Online event

Sales Have Ended

Registrations are closed
If you wish to receive a recording of this event, please contact comms@ct.catapult.org.uk
Event description
Accelerating commercialisation and translation of your cell and gene therapy research

About this event

Join via this link: https://ukri.zoom.us/j/98956029885

You are invited to take part in an afternoon seminar event for advanced therapy researchers on Wednesday 21 October 2020, 13.00-15.00. The event is hosted jointly by Cell and Gene Therapy Catapult and the University of Oxford.

The virtual event comprises a series of talks, breakouts and panel discussion on the key considerations for commercialisation and translation of cell and gene therapy research, and how to prepare and ensure commercial success for your advanced therapy projects.

Sessions include:

  • Overcoming barriers to scale-up manufacturing
  • Addressing current and future pre-clinical ATMP development and regulatory needs
  • Considering your intellectual property and commercial needs

Would like to receive tailored feedback from our team on your project idea or proposal? Please indicate this during the Eventbrite registration process by giving a brief summary (100-150 words) of your project and questions you would like to discuss with CGT Catapult experts.Virtual one-to-one meetings will be scheduled with CGT Catapult after the seminar at a mutually convenient time. We hope you will be able to join us.

After registration via EventBrite, you will receive an access link to the virutal event up to one week before the event sent to the email address provided during registration.

Agenda

  • Welcome - Dr Sam Goldsmith, University Liaison Manager, CGT Catapult
  • Introduction to CGT Catapult and our ambitions for realising the commercial potential of your cell and gene therapy research - Dr Jonathan Appleby, CSO, CGT Catapult
  • Case Study - Profesor Robert MacLaren, Professor of Ophthalmology, University of Oxford
  • Introduction to scale-up manufacturing - Dr Mustafa Munye, Lead Scientist, CGT Catapult
  • Introduction to non-clinical development and regulatory needs - Dr Valeria Iansante, Non-Clinical Manager, CGT Catapult
  • Introduction to intellectual property - Dr Matthew Garner, Head of IP, CGT Catapult
  • Breakout room discussion on key topics listed above
  • Panel discussion with Q&A: How to build a robust commercialisation strategy - All speakers

Date and time

Location

Online event

Save This Event

Event Saved